Indirect Cost Burden of Migraine in the United States

Objective: The purpose of this study was to determine the indirect cost burden associated with migraine. Methods: Data were obtained from Thomson-Medstat's Health and Productivity Management (HPM) database for the 2002 through 2003 calendar years. The migraine cohort was composed of patients who had a diagnosis of migraine or migraine-specific abortive prescription medication, or both. A control cohort of patients without migraine was matched to patients in the migraine cohort. The average annual indirect burden of illness (BOI) of migraine and a national indirect BOI were estimated. Results: Annual indirect expenditures were significantly higher in the migraine group compared with the control group ($4453 vs $1619; P < 0.001). The national annual indirect BOI, excluding presenteeism, was estimated to be $12 billion (mostly attributed to absenteeism). Conclusions: Migraine imparts a substantial indirect cost burden. Projected to a national level, this amounts to an annual cost to US employers of approximately $12 billion.

[1]  R. Lipton,et al.  Lost productive time and cost due to common pain conditions in the US workforce. , 2003, JAMA.

[2]  Ron Z. Goetzel,et al.  Health, Absence, Disability, and Presenteeism Cost Estimates of Certain Physical and Mental Health Conditions Affecting U.S. Employers , 2004, Journal of occupational and environmental medicine.

[3]  R. Goetzel,et al.  The Impact of Rheumatoid Arthritis on Medical Expenditures, Absenteeism, and Short-Term Disability Benefits , 2006, Journal of occupational and environmental medicine.

[4]  S. Kryst,et al.  A Population‐Based Survey of the Social and Personal Impact of Headache , 1994, Headache.

[5]  S. Bolge,et al.  The impact of migraine on work, family, and leisure among young women – a multinational study , 2004, Current medical research and opinion.

[6]  D. Nerenz,et al.  A Psychiatric Patient Classification System: An Alternative to Diagnosis-Related Groups , 1989, Medical care.

[7]  W F Stewart,et al.  Burden of migraine in the United States: disability and economic costs. , 1999, Archives of internal medicine.

[8]  J. Edmeads,et al.  The Economic Impact of Migraine: An Analysis of Direct and Indirect Costs , 2002, Headache.

[9]  R. F. Nelson,et al.  Impact of Migraine and Tension-Type Headache on Life-Style, Consulting Behaviour, and Medication Use: A Canadian Population Survey , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[10]  A Bouckaert,et al.  Practical considerations on the use of the Charlson comorbidity index with administrative data bases. , 1996, Journal of clinical epidemiology.

[11]  G. Solomon,et al.  The burden of migraine to the individual suffer: a review , 1998, European journal of neurology.

[12]  R. Lipton,et al.  Migraine: Epidemiology, Impact, and Risk Factors for Progression , 2005, Headache.

[13]  W. Burton,et al.  Cutting the costs of migraine: role of the employee health unit. , 1998, Journal of occupational and environmental medicine.

[14]  Walter F. Stewart,et al.  Burden of migraine , 1997, Neurology.

[15]  G. Solomon,et al.  Burden of migraine. A review of its socioeconomic impact. , 1997, PharmacoEconomics.

[16]  R. Lipton,et al.  Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II , 2001, Headache.